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Background: Fat grafting is a growing field within plastic surgery. Adipose-derived
stem cells (ASCs) and stromal vascular fracture (SVF) may have a role in fat graft
survival. Our group previously demonstrated a detrimental effect on ASC survival
by the lidocaine used in tumescent solution. Sodium bicarbonate (SB) buffers the
acidity of lidocaine. The purpose of this study was to determine whether SB buffering is a practical method to reduce ASC and SVF apoptosis and necrosis seen with
common lidocaine-containing tumescent solution.
Methods: Human patients undergoing bilateral liposuction for any indication were
included in this study. An internally controlled, split-body design was utilized. Tumescent liposuction on one side of the body was conducted with tumescent containing lidocaine. On the opposite side, liposuction was conducted by adding SB to
the tumescent. Tumescent solution and lipoaspirate pH were measured. Lipoaspirate from each side was processed for SVF isolation and ASC culture. The number
of viable ASCs was counted and SVF apoptosis/necrosis was examined.
Results: The pH of the SB-buffered tumescent was significantly higher than that
of the standard tumescent, an effect also seen in the lipoaspirate. Adipose-derived
stem cell survival in the SB-buffered lipoaspirate was approximately 53% higher.
However, there was no significant difference in SVF apoptosis and necrosis between the groups.
Conclusions: The acidic standard tumescent solution commonly used in liposuction diminishes ASC viability from lipoaspirates. Sodium bicarbonate buffering tumescent solution can enhance ASC viability, but does not affect SVF apoptosis and
necrosis. We recommend buffering tumescent with SB to potentially improve fat
graft take. Our findings advocate for further research investigating mechanisms
and optimal harvest techniques that maximize SVF/ASC survival and the clinical
effect on overall fat graft viability. (Plast Reconstr Surg Glob Open 2019;7:e2138; doi:
10.1097/GOX.0000000000002138; Published online 20 March 2019.)

INTRODUCTION

Liposuction is a popular procedure in plastic surgery.
Tumescent anesthesia is widely accepted as a standard
technique in large-volume liposuction.1,2 Tumescent anFrom the Department of Surgery, Division of Plastic Surgery,
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esthesia can be achieved by infusing large volumes of
Ringer’s solution containing dilute anesthetic such as
lidocaine with epinephrine.3–6 However, commercially
available Ringer’s solution and lidocaine and epinephrine are acidic and can cause perioperative and postoperative pain. Recently, several studies have demonstrated
the benefits of neutralization of tumescent solution.
For example, Wallace et al7 reported that buffering of
tumescent anesthetic solution with sodium bicarbonate
(SB) is a simple, safe, inexpensive, and effective means to
reduce perioperative and postoperative pain. Best et al8
also showed that buffering tumescent solution to neutral
pH with SB is a practical method to mitigate the burning
sensation.
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in relation to the content of this article.
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Human lipoaspirate harvested by liposuction is an ideal
filler for reconstruction of soft-tissue defects.9,10 The main
drawback of fat grafting historically cited was graft resorption, which has shown graft volume loss to vary between
20% and 90% at 1 year after transplantation.11–13 However,
more recently, large-volume fat grafting has been performed reliably with high retention rates by adhering to
principles of fat grafting: optimizing recipient site capacity,
graft harvest/preparation, and precision graft delivery.14 In
recent years, fat grafting using autogenic lipoaspirate with
enrichment of adipose-derived stem cells (ASCs) or stromal
vascular fraction (SVF) has gained popularity in aesthetic
surgery.15–20 Although ASCs and SVF are a minor fraction
of lipoaspirate, investigators have postulated that their high
potential for self-renewal, multilineage differentiation, and
higher yield may compensate for some of the graft volume
loss and may improve graft take.19,20 A thorough literature
search indicated that the effect of SB on the viability of ASC
and SVF has not been studied. The purpose of the present study is to determine whether acidic tumescent solution
used in liposuction is harmful to ASC and SVF viability, and
whether SB buffering is a practical method to reduce ASC
and SVF cell death.

METHODS
Experimental Protocol

Human lipoaspirate was harvested from adults undergoing outpatient, cosmetic or reconstructive liposuction procedures with associated fat grafting. All the participants were
provided informed consent and agreed to inclusion into the
study. The Institutional Review Board at the University Medical Center approved all the protocols involving human tissue
and cells. Lipoaspirate was harvested via standard liposuction techniques by a single plastic surgeon (R.C.B.). In brief,
through a 4-mm incision, wetting solution was infiltrated into
the subcutaneous fat at a ratio of 1:1 (infiltrate volume: aspirate volume). The lipoaspirate was procured using a blunttipped 3.7-mm Mercedes cannula, machine suction, and
was collected in a sterile canister for processing. For quality
control, only individuals who underwent liposuction on bilateral body areas were included. Under general anesthesia, tumescent liposuction on one side of the body was conducted
with the standard tumescent (1,000 mL of lactated Ringer’s
solution with 30 mL of 1% lidocaine and 1 μg/mL epinephrine) without SB. On the opposite side, liposuction with SB
buffering was conducted by adding 7 mL of 8.4% SB to the
standard tumescent. The pH in the tumescent solution and
lipoaspirate were measured in each sample. The harvested lipoaspirate from each liposuction was processed for SVF isolation. The number of adherent ASCs, reflecting viability, was
counted after 24 hours of SVF culture. Live, apoptotic, and
necrotic of SVF cells were stained by Annexin V-fluorescein
isothiocyanate (FITC)/Propidium iodide (PI) and quantitatively analyzed by flow cytometry.
Isolation of SVF

The method for SVF isolation has been previously described by our group.20–25 Briefly, 5 mL of lipoaspirate from
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each liposuction side was processed. Lipoaspirate samples
were then centrifuged at 430g for 10 minutes. After oil
removal, the lipid phase of the lipoaspirate was harvested
from the top of the conical tube and then diluted with
an equal volume of collagenase digestion solution (final
concentration: 0.3 U/mL; Collagenase NB 4G proved
grade, Serva Electrophoresis, Heidelberg, Germany).
After 30 minutes of incubation, an equal volume of Dulbecco’s Modified Eagle Medium containing 20% fetal bovine serum (FBS) was added to end enzymatic digestion.
The floating layer containing adipocytes and the pellet
containing SVF were separated by centrifugation. The isolated SVF was filtered through a 100-µm nylon filter and
processed for density gradient by centrifugation with Histopaque-1077 (Sigma-Aldrich, St. Louis, Mo.). The white
band (mononuclear cells) remaining at the plasma interface was carefully aspirated and the total number of SVF
cells was counted. Harvested SVF was then either cultured
in nonhematopoietic expansion medium (Miltenyi Biotec, Auburn, Calif.) for ASC purification or stained by Annexin V-FITC/PI and analyzed by flow cytometry.
Purification of ASCs through SVF Culture

SVF is highly heterogeneous and contains many cell
subsets including ASCs, endothelial cells, hematopoietic
cells, etc. One of the characteristics of ASC is that they
are adherent to the plastic surface. Therefore, isolation
of ASC can be achieved through SVF culture. In brief, all
the isolated SVF cells from the lipoaspirate sample were
added into a 75 cm2 cell culture flask containing 15 mL
of prewarm nonhematopoietic expansion medium and
1% of Penicillin–Streptomycin. The flask was cultivated
at 37ºC, 5% CO2, and 95% humidity. After 24 hours of
culture, the nonadherent cells in the flask were removed
by PBS washing. Trypsin/ethylenediaminetetraacetic acid
(EDTA) 1 mL was added into the flask and incubated at
37°C for 10 minutes. After complete dissociation, the total
number of adherent ASC was harvested and counted.
Detection of Apoptotic and Necrotic Cells in SVF
Populations

The apoptosis and necrosis of SVF cells were detected
by Annexin V-FITC/PI assay.20–25 Briefly, 1 × 105 SVF cells
were washed with 1 mL of binding buffer followed by centrifugation. After supernatant removal, SVF cells were suspended in 100 µL of binding buffer with 10 µL of Annexin
V-FITC or without (unstained control). Following 15 minutes of incubation in the dark, SVF cells were washed
again by 1 mL of binding buffer and then centrifugation.
After supernatant removal, SVF cells were suspended in
500 µL of binding buffer with 5 µL of PI or without (unstained control). Two tubes were used to set up compensation and quadrants with: (1) unstained and (2) stained
with Annexin V-FITC and PI. Necrosis was determined by
PI and apoptosis was determined by Annexin V-FITC. Ten
thousand SVF cells from each sample were scanned and
analyzed by flow cytometer. Data acquisition and analysis
were performed by flow cytometer with BD FACS Aria III
software v6.1.3 (Becton Dickinson, San Jose, Calif.) using
an excitation wavelength of 488 nm with an argon laser.
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Statistical Analysis

We have analyzed the continuous response variable from matched pairs of study subjects in our previous studies.21–26 Our prior preliminary data based on 7
subjects indicate that the difference in the response of
matched pairs is normally distributed with SD 386.7 and
the difference between means is 514.3. If the true difference of ASC number in the mean response of matched
pairs is 514.3, we will need to study 6–8 pairs of subjects
to be able to reject the null hypothesis with probability
(power) 0.9 (90%). The Type I error probability (P value) associated with this test of this null hypothesis is 0.05.

RESULTS

The participants (n = 7/group) were all female
adults. There were no children, no pregnant woman, or
prisoners. There were no exclusions based on gender,
race/ethnicity, or medical conditions. The study completed after 10 months of participant accrual. The average age of the participants was 57 ± 5.0 years (±standard
error of the mean; SEM) and the average body mass index was 30 ± 2.0 (±SEM). Liposuction sites included the
flank and abdomen. The pH of the modified tumescent solution with SB (Fig. 1) was significantly higher
than standard solution (7.06 ± 0.05 versus 6.17 ± 0.1,
P = 0.001). The pH of lipoaspirate treated with SB (Fig. 2)
was significantly higher compared with nonbuffered
lipoaspirate (6.81 ± 0.06 versus 6.67 ± 0.03, P = 0.043).
The average number of viable ASCs in the lipoaspirate
treated with SB (Fig. 3) was approximately 53% higher
(377,214 ± 125,505 versus 245,643 ± 81,971, P = 0.028) than
that in the lipoaspirate from standard tumescent. In the
Annexin V-FITC/PI assay for SVF viability (Fig. 4), however, we found that SB did not show any significant effect on
SVF cell survival, apoptosis, and necrosis. In the tumescent
with SB group, the average percentage of live SVF cells was
68% ± 10%, apoptotic cells were 23% ± 7%, and necrotic
cells were 9% ± 4%. In the tumescent without SB group,
the average percentage of live cells was 79% ± 7%, apoptotic cells were 20% ± 6%, and necrotic cells was 8% ± 4%.
There was no significant difference between SB-treated
and SB-untreated groups.

Fig. 1. The pH (±SEM) of the modified tumescent solution with SB
(blue) was significantly higher than that of the standard tumescent
solution (green; 7.06 ± 0.05 vs. 6.17 ± 0.1). * indicates statistically
significant differences (P = 0.001) between tumescent with SB and
tumescent without SB.

Fig. 2. The pH (±SEM) in the lipoaspirate treated with SB (blue) was
significantly higher compared to that in the lipoaspirate treated
with standard tumescent solution (green; 6.81 ± 0.06 vs. 6.67 ± 0.03).
* indicates statistically significant differences (P = 0.04) between lipoaspirate with SB and lipoaspirate without SB.

Discussion

Several studies7,8 have shown that a tumescent-induced
perioperative and postoperative burning sensation is related to the acidic pH of the solution. All the compositions
in the standard tumescent solution, including lactated
Ringer’s solution, lidocaine, and epinephrine, are acidic. Data from other laboratories7,8 indicate that 1% lidocaine with epinephrine has a pH of 4.38, and even when
diluted to 0.1%, the solution remains significantly below
physiological pH at 6.32. Sodium bicarbonate is a chemical compound with the formula NaHCO3. It is a salt composed of sodium ions and bicarbonate ions. Postulating
that the acidic nature of lidocaine contributed the pain
on intradermal infiltration, multiple groups not only established the feasibility of using SB to neutralize lidocaine
to a physiological pH, but also demonstrated pain attenuation.27,28 Since then, several reports29,30 have suggested that
the neutralization of tumescent anesthetic solution with
SB is a simple, safe, inexpensive, and effective means to
reduce perioperative and postoperative pain.

Fig. 3. Average number (±SEM) of adherent (viable) ASCs in the
lipoaspirate treated with SB (blue) was approximately 53% higher
(377,214 ± 125,505 vs. 245,643 ± 81,971) than that in the lipoaspirate
treated without SB (green). * indicates statistically significant differences (P = 0.028) between lipoaspirate with SB and lipoaspirate
without SB.
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Fig. 4. In the Annexin V-FITC/PI assay for Please incorporate the following change: SVF viability, no
significant difference was found on the average percentage (±SEM) of viable SVF cells between the
buffered lipoaspirate and the lipoaspirate treated without SB. *P = 0.171, †P = 0.165, and ‡P = 0.185.

Our previous studies21,26 have demonstrated that lidocaine has a negative impact on ASC survival. Removing
lidocaine from tumescent solution significantly reduced
SVF and ASC cells apoptosis from the standard tumescent liposuction with lidocaine. It is unclear if the toxicity
of lidocaine to the cells is attributed to the acidic pH of
tumescent solution. In the present study, we attempt to
determine if the acidic tumescent solution used in liposuction is harmful to ASC and SVF viability, and if SB buffering is a practical method to reduce ASC and SVF cell
death and apoptosis. Our results showed that adding 7 mL
of 8.4% SB not only significantly neutralized tumescent solution to a physiological pH at 7.06 but also considerably
increased lipoaspirate pH from 6.67 to 6.81. As a result
of this pH modification in tumescent solution, the number of adherent ASC was significantly enhanced in the SB
treated lipoaspirate, which was 53% higher than that in
the untreated lipoaspirate.
In the present study, cell viability of the adherent ASCs
was not measured. One of the unique characteristics of
viable ASCs is that they adhere to plastic surfaces. This
phenomenon is the foundation for current ongoing ASC
research.31–33 Most nonadherent cells (either non-ASCs or
dead ASCs) in the flask were removed by PBS washing after
24 hours culture of SVF cells. In our previous studies,21–26
we found that about 90% of adherent cells to the plastic
surface after 24 hours culture of SVF were viable (negative
for both Annexin V-FITC and PI) and the ethanol-treated
dead ASCs were unable to adhere to the plastic surface in
the culture flask. We believe that the dead ASCs may lose
their ability to adhere and could have been removed by
PBS washing or medium change. Therefore, the adherent
cells from SVF culture can be defined not only as ASCs but
also as viable ASCs.
Just like ASCs, SVF possesses similar potential in regenerative medicine and has far-reaching clinical implications.11–13,15–19 Some investigators have suggested that
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SVF may even have an advantage over ASCs because of
the presence of endothelial progenitor cells, pericytes, immune cells, and other stromal components along with the
ASCs.11 Stromal vascular fracture cells are relatively easy
and quick to obtain in large quantities without the need
for processing or cell culture; therefore, both liposuction
and SVF transplantation procedures can be accomplished
in the same day. Moreover, the clinical application of SVF
is not currently restricted by the United States Food and
Drug Administration (FDA). In recent years, liposuction
followed by fat grafting with SVF enrichment has gained
popularity in aesthetic surgery. Several studies15–18 have
shown SVF to be effective as a regenerative cell therapy in
treating chronic conditions ranging from arthritis, diabetes mellitus, chronic wounds, breast cancer, and radiation
injuries. However, SVF viability in the lipoaspirate before
fat grafting is not well described in the literature. The
amount of SVF in the lipoaspirate can be variable among
different populations such as overweight versus lean, aged
versus young, diabetic versus healthy, different locations
such as abdomen versus thigh, etc., and different liposuction techniques.34–36 To control these variances, we standardized the liposuction techniques with a single plastic
surgeon and excluded individuals who underwent liposuction only on unilateral body areas. Therefore, the influence of the variances is largely diminished or controlled
because both samples (with SB or without SB) came from
the symmetrical pairs of the same individual.
One of the purposes of the present study was to determine whether acidic tumescent solution used in liposuction is harmful to SVF viability, and whether SB
buffering can reduce SVF cell death and apoptosis in the
lipoaspirate. Stromal vascular fracture apoptosis and necrosis were examined by Annexin V-FITC/PI staining with
flow cytometry. Unfortunately, our results did not detect
a significant difference in SVF apoptosis and necrosis between SB-treated and SB-untreated lipoaspirates. This is
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probably due to the fact that SVF contains multiple cell
populations, whereas ASCs are a single cell population, so
cell numbers of certain types may change without affecting the total SVF. Buffering tumescent solution with SB
may be sensitive to ASCs, but not sensitive to other cell
populations of SVF. Nevertheless, further study is warranted to explore the mechanism.
Additionally, although our results demonstrate an improvement in ASC viability following bicarbonate buffering,
it is unclear whether this effect translates to an enhanced
outcome with respect to fat graft survival and volume retention over time. This question is important clinically and
is an area of current investigation by our group.

CONCLUSIONS

The acidic standard tumescent solution used in liposuction adversely affects the cell viability of ASCs isolated
from lipoaspirates. Buffering tumescent solution with SB
can significantly enhance ASC viability. The implication
of potentially improved fat graft take is promising and
prompts our continued investigation.
Ashish Francis, MD
Division of Plastic Surgery
University of Nevada
Las Vegas School of Medicine
1701 W. Charleston Blvd., Suite 400
Las Vegas, NV 89102
E-mail: ashish.francis@unlv.edu
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